This technology harnesses the power of patients» very immune cells — which are extracted from them, reengineered in a lab, and then pumped back into the body — to kill aggressive blood cancers. (fortune.com)
It's the first CAR - T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers. (scientificamerican.com)
Chimeric antigen receptor (CAR) T cell therapy, which edits a cancer patient's T cells to recognize their tumors, has successfully helped patients with aggressive blood cancers but has yet to show the ability to treat solid tumors. (sciencedaily.com)